Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human fibrinogen in congenital fibrinogen deficiency: PK and phase III study
CTR20192419Phase 3Completed
- Sponsor
- Chengdu Rongsheng Pharmaceutical
- Start
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Fibrinogen human in fibrinogen deficiency, congenital hypofibrinogenemia, sponsored by Chengdu Rongsheng Pharmaceutical. Started Jan 2020; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
fibrinogen deficiencycongenital hypofibrinogenemia
Beyond the preview
Go deeper on CTR20192419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192419.